Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mammary polyadenomatosis is characterized by the presence in both breasts of multiple voluminous fibroadenomas with heterogeneous echo patterns.
Features include: Fibroadenoma of the breast.
PRLR function has not been fully characterized.
Multiple fibroadenoma of the breast is associated with mutations in the PRLR gene on chromosome 5.
Genetic testing for PRLR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for multiple fibroadenoma of the breast has been reported in the published literature.
No clinical trials have been registered for multiple fibroadenoma of the breast.
13 publications have been identified in PubMed for multiple fibroadenoma of the breast. Research spans Case Report / Case Series (62%), Review / Meta-Analysis (15%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 62% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Research summaries
2 |
15% |
Laboratory research | 2 | 15% |
Testing and diagnosis research | 1 | 8% |
Heilat GB (2026). [PMID: 42700455](https://pubmed.ncbi.nlm.nih.gov/42700455/). *Future Sci OA*. [Case Report / Case Series]
Ingyin H (2026). [PMID: 41456879](https://pubmed.ncbi.nlm.nih.gov/41456879/). *Histopathology*. [Basic Science / Preclinical]
Wang XR (2026). [PMID: 41924605](https://pubmed.ncbi.nlm.nih.gov/41924605/). *Front Oncol*. [Case Report / Case Series]
Math P (2026). [PMID: 41919577](https://pubmed.ncbi.nlm.nih.gov/41919577/). *Breast J*. [Review / Meta-Analysis]
Spoorthy Rekha YC (2025). [PMID: 39350750](https://pubmed.ncbi.nlm.nih.gov/39350750/). *Int J Surg Pathol*. [Review / Meta-Analysis]
Uozumi N (2025). [PMID: 40385736](https://pubmed.ncbi.nlm.nih.gov/40385736/). *Cureus*. [Case Report / Case Series]
Zhang M (2025). [PMID: 41458625](https://pubmed.ncbi.nlm.nih.gov/41458625/). *Front Oncol*. [Case Report / Case Series]
Fiengo E (2025). [PMID: 41464842](https://pubmed.ncbi.nlm.nih.gov/41464842/). *J Clin Med*. [Diagnostic / Biomarker]
Wang C (2025). [PMID: 41476592](https://pubmed.ncbi.nlm.nih.gov/41476592/). *Front Oncol*. [Case Report / Case Series]
Zhou Y (2025). [PMID: 40338490](https://pubmed.ncbi.nlm.nih.gov/40338490/). *Inflammation*. [Basic Science / Preclinical]